Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and Whites

Abstract African Americans (blacks) have a disproportionately high incidence of end-stage renal disease due to hypertension. The Modification of Diet in Renal Disease (MDRD) Study found that strict blood pressure control slowed the decline in glomerular filtration rate (GFR) only in the subgroup of patients with proteinuria. The present report compares the effects of blood pressure control in black and white MDRD Study participants. Fifty-three black and 495 white participants with baseline GFRs of 25 to 55 mL/min/1.73 m 2 were randomly assigned to a usual or low mean arterial pressure (MAP) goal of ≤107 or ≤92 mm Hg, respectively. GFR decline was compared between randomized groups and correlated with the level of achieved blood pressure. The mean (±SE) GFR decline over 3 years in the low blood pressure group was 11.8±7.3 mL/min slower than in the usual blood pressure group among blacks ( P =.11) compared with 0.3±1.3 mL/min slower among whites ( P =.81) ( P =.12 between blacks and whites). In both blacks and whites, higher baseline urine protein excretion was associated with a greater beneficial effect of the low MAP goal on GFR decline ( P =.02 for both races). Combining both blood pressure groups and controlling for baseline characteristics, higher follow-up achieved MAP was associated with faster GFR decline in both blacks ( P P =.002), with a sevenfold stronger relationship in blacks ( P 1 g/d). In addition, a lower level of blood pressure control may be even more important in blacks than in whites in slowing the progression of renal disease.

[1]  C J McDonald,et al.  Renal disease in hypertensive adults: effect of race and type II diabetes mellitus. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  G. Beck,et al.  Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the modification of diet in renal disease study: Modification of diet in renal disease study group , 1996 .

[3]  G. Beck,et al.  Utility of Radioisotopic Filtration Markers in Chronic Renal Issufficiency: Simultaneous Comparison of 125I-Iothalamate, 169Yb-DTPA, 99mTc-DTPA, and Inulin , 1990 .

[4]  T. Greene,et al.  Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.

[5]  A. Levey,et al.  Effects of dietary protein restriction on the progression of moderate renal disease in the modification of diet in renal disease study: Modification of Diet in Renal Disease Study Group , 1996 .

[6]  J. Cutler,et al.  The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. , 1988, Archives of internal medicine.

[7]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[8]  G H Guyatt,et al.  A Consumer's Guide to Subgroup Analyses , 1992, Annals of Internal Medicine.

[9]  S. Rosansky,et al.  The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. , 1990, Archives of internal medicine.

[10]  A. Levey,et al.  Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  R. Toto,et al.  "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis. , 1995, Kidney international.

[12]  J. Bednarz,et al.  Diurnal blood pressure variation and cardiac mass in American blacks and whites and South African blacks. , 1992, American journal of hypertension.

[13]  George W. Williams,et al.  The modification of diet in renal disease study group , 1991 .

[14]  J. Cutler,et al.  Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. , 1992 .

[15]  P. Whelton,et al.  Hypertension as a Risk Factor for Renal Disease Review of Clinical and Epidemiological Evidence , 1989, Hypertension.

[16]  C. Bulpitt,et al.  How far should blood pressure be lowered? , 1992, The New England journal of medicine.

[17]  M. Taylor,et al.  Correlates of attendance and compliance in the hypertension detection and follow-up program. , 1982, Controlled clinical trials.

[18]  R. Toto,et al.  Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. , 1996, Controlled clinical trials.

[19]  H. Dustan,et al.  Renal insufficiency in treated essential hypertension. , 1989, The New England journal of medicine.

[20]  G. Beck,et al.  Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. , 1997, Kidney international.

[21]  M. Blaufox,et al.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.

[22]  P. Brazy,et al.  Progressive renal disease: role of race and antihypertensive medications. , 1990, Kidney international.

[23]  Paul E. Teschan,et al.  Glomerular filtration rate measurements in clinical trials , 1993 .

[24]  G. Striker,et al.  The Division of Kidney, Urologic, and Hematologic Diseases: Initiative for Research on Kidney Diseases and Hypertension in Blacks , 1993 .

[25]  W. McClellan,et al.  Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  L. Snetselaar,et al.  Baseline characteristics in the Modification of Diet in Renal Disease Study. , 1993, Journal of the American Society of Nephrology : JASN.

[27]  N. Levinsky,et al.  Kidney Failure and the Federal Government , 1992, Annals of Internal Medicine.

[28]  G. Somes,et al.  Sodium Excretion and Racial Differences in Ambulatory Blood Pressure Patterns , 1991, Hypertension.

[29]  J. Connett,et al.  Responses of black and white males to the special intervention program of the Multiple Risk Factor Intervention Trial. , 1984, American heart journal.

[30]  J. Kusek,et al.  Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. , 1991, Controlled clinical trials.

[31]  Can we prevent end-stage renal disease due to hypertension or to diabetes mellitus? , 1992, JAMA.

[32]  A. Levey,et al.  Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. , 1997, Hypertension.

[33]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[34]  N. Levinsky,et al.  The Medicare end-stage renal disease program. A report from the Institute of Medicine. , 1991, The New England journal of medicine.

[35]  P. Whelton,et al.  Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? , 1991, Archives of internal medicine.

[36]  J. Cramer,et al.  Patient recruitment in clinical trials , 1992 .

[37]  A. Dannenberg,et al.  Blood pressure levels in persons 18-74 years of age in 1976-80, and trends in blood pressure from 1960 to 1980 in the United States. , 1986, Vital and health statistics. Series 11, Data from the National Health Survey.

[38]  W. Mitch,et al.  A method for estimating nitrogen intake of patients with chronic renal failure. , 1985, Kidney international.